Literature DB >> 8081288

Comparison of five methods for the detection of antiribosomal P protein antibody.

E Bonfa1, N Gaburo Júnior, A V Tavares, W Cossermelli.   

Abstract

1. We have compared the sensitivity and specificity of immunofluorescence, counterimmunoelectrophoresis, immunodiffusion, Western blotting and ELISA for the detection of antiribosomal P protein antibodies using 153 lupus sera. 2. Western blotting and ELISA were the 2 most sensitive and specific techniques for the detection of these antibodies. In contrast, cytoplasmic immunofluorescence was observed in only one third of the anti-P-positive patients. Immunodiffusion and counterimmunoelectrophoresis, although highly specific, detecting 14% and 29% of all anti-P-positive sera by Western blotting, were the least sensitive tests. 3. The frequency of anti-P in lupus patients, as detected by Western blotting analysis was 18%. The most frequently observed antibody in anti-P sera was anti-Ro/SSA (39%). Anti-P antibodies were also detected in the sera of 3 patients with negative nuclear immunofluorescence. 4. Anti-P is an additional serological marker for systemic lupus erythematosus and Western blotting is the method of choice for detecting this antibody due to the limited availability of the fusion protein in Brazil.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8081288

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  5 in total

1.  Technical and clinical evaluation of anti-ribosomal P protein immunoassays.

Authors:  M Mahler; K Kessenbrock; J Raats; M J Fritzler
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

2.  Autoimmune hemolytic anemia in systemic lupus erythematosus: association with thrombocytopenia.

Authors:  Diogo Souza Domiciano; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2010-05-15       Impact factor: 2.980

3.  The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.

Authors:  A G Tzioufas; N G Tzortzakis; E Panou-Pomonis; K A Boki; M Sakarellos-Daitsiotis; C Sakarellos; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

4.  AIT test has no problem in the detection of anti-ribosomal P--authors' response.

Authors:  Michael Mahler; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2009-08-25       Impact factor: 5.156

Review 5.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.